XYL:NYSEXylem Inc. Analysis
Data as of 2026-09-02 - not real-time
$106.89
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
At $106.89, Xylem Inc. shows a bearish moving-average alignment, with shorter averages beneath longer ones. Across the trailing 30 sessions it lost 8.6%. Relative strength is 29.6 — oversold — and the MACD signal is bearish. The recent range runs from support at $106.59 up to resistance at $124.00.
Multiples put this in undervalued territory: 25.4 times earnings against the sector's 28.6. Consensus targets land 44.0% above where the shares trade now. The 1.61% dividend yield looks covered by current payout levels.
Risk scores 6 out of 10, which is elevated for this asset class. With 30-day volatility of 29.3%, a beta of 0.81 and a maximum drawdown of 30.5%, position sizing matters here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
This one splits by horizon — hold in the near term, buy further out, at 4/10 long-term conviction.
Multiples put this in undervalued territory: 25.4 times earnings against the sector's 28.6. Consensus targets land 44.0% above where the shares trade now. The 1.61% dividend yield looks covered by current payout levels.
Risk scores 6 out of 10, which is elevated for this asset class. With 30-day volatility of 29.3%, a beta of 0.81 and a maximum drawdown of 30.5%, position sizing matters here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
This one splits by horizon — hold in the near term, buy further out, at 4/10 long-term conviction.
Top Market Events
What Happened? Shares of water technology company Xylem NYSE:XYL jumped 4.4% in the morning session after the company...Xylem beat adjusted earnings by 9% and lifted full-year profit guidance on surging orders of $3.Water technology company Xylem NYSE:XYL met Wall Street’s revenue expectations in Q2 CY2026, with sales up 1.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 2/10
Key Factors
- Short-term moving averages stacked below long-term ones
- RSI at 29.6 signals oversold conditions
- Trading below the 200-day average of 124.80
Medium Term
1–3 yearsNeutral
Model confidence: 2/10
Key Factors
- Short-term moving averages stacked below long-term ones
- RSI at 29.6 signals oversold conditions
- P/E of 25.4 versus sector average of 28.6
Long Term
> 3 yearsPositive
Model confidence: 4/10
Key Factors
- P/E of 25.4 versus sector average of 28.6
- Analyst targets imply +44.0% versus the current price
- Dividend yield of 1.61%
Key Metrics & Analysis
Financial Health
Revenue Growth1.50%
Profit Margin11.15%
P/E Ratio25.4
ROE9.18%
ROA5.11%
Debt/Equity28.64
P/B Ratio2.3
Op. Cash Flow$1.3B
Free Cash Flow$1.2B
Industry P/E28.6
Technical Analysis
TrendBearish
RSI29.6
Support$106.59
Resistance$124.00
MA 20$116.27
MA 50$117.91
MA 200$124.80
MACDBearish
VolumeIncreasing
Fear & Greed Index92.57
Valuation
Fair Value$61.05
Target Price$153.88
Upside/Downside43.96%
GradeUndervalued
TypeBlend
Dividend Yield1.61%
Risk Assessment
Beta0.81
Volatility29.32%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.